Report Detail
Global (United States, European Union and China) Conjugate Vaccines Market Research Report 2019-2025
- RnM3682120 |
- 19 August, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Other
Conjugate vaccines refer to those vaccines that contain bacterial capsule polysaccharide or the antigen attached or conjugated to a protein.
This protein has a key role in enhancing the immunogenic property of the polysaccharide. These vaccines are mainly used to immunize infants and children against invasive disease caused by Hib bacteria, H. influenzae, Streptococcus pneumoniae, and Neisseria meningitidis.
The increase in use of conjugate vaccines for adults, rise in number of regulatory approvals for conjugate vaccines, growth in prevalence of diseases caused by microorganisms such as Streptococcus pneumoniae and Neisseria meningitidis, and technological advancements majorly drive the growth of the market. In contrast, low accessibility to vaccines in remote areas and complex production procedure of conjugate vaccine restraint the market growth.
In 2019, the market size of Conjugate Vaccines is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Conjugate Vaccines.
This report studies the global market size of Conjugate Vaccines, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Conjugate Vaccines production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Novartis
Neuron Biotech
Serum Institute of India
Pfizer
Sanofi Pasteur
Bharat Biotech
Biological
GlaxoSmithKline
Merck
CSL
Market Segment by Product Type
Monovalent Conjugate Vaccines
Multivalent Conjugate Vaccines
Market Segment by Application
Pediatrics
Adults
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Conjugate Vaccines status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Conjugate Vaccines manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Conjugate Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Conjugate Vaccines Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Monovalent Conjugate Vaccines
- 1.3.3 Multivalent Conjugate Vaccines
- 1.4 Market Segment by Application
- 1.4.1 Global Conjugate Vaccines Market Share by Application (2019-2025)
- 1.4.2 Pediatrics
- 1.4.3 Adults
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Conjugate Vaccines Production Value 2014-2025
- 2.1.2 Global Conjugate Vaccines Production 2014-2025
- 2.1.3 Global Conjugate Vaccines Capacity 2014-2025
- 2.1.4 Global Conjugate Vaccines Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Conjugate Vaccines Market Size CAGR of Key Regions
- 2.2.2 Global Conjugate Vaccines Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Conjugate Vaccines Capacity by Manufacturers
- 3.1.2 Global Conjugate Vaccines Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Conjugate Vaccines Revenue by Manufacturers (2014-2019)
- 3.2.2 Conjugate Vaccines Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Conjugate Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.3 Conjugate Vaccines Price by Manufacturers
- 3.4 Key Manufacturers Conjugate Vaccines Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Conjugate Vaccines Market
- 3.6 Key Manufacturers Conjugate Vaccines Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Monovalent Conjugate Vaccines Production and Production Value (2014-2019)
- 4.1.2 Multivalent Conjugate Vaccines Production and Production Value (2014-2019)
- 4.2 Global Conjugate Vaccines Production Market Share by Type
- 4.3 Global Conjugate Vaccines Production Value Market Share by Type
- 4.4 Conjugate Vaccines Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Conjugate Vaccines Consumption by Application
6 Production by Regions
- 6.1 Global Conjugate Vaccines Production (History Data) by Regions 2014-2019
- 6.2 Global Conjugate Vaccines Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Conjugate Vaccines Production Growth Rate 2014-2019
- 6.3.2 United States Conjugate Vaccines Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Conjugate Vaccines Import & Export
- 6.4 European Union
- 6.4.1 European Union Conjugate Vaccines Production Growth Rate 2014-2019
- 6.4.2 European Union Conjugate Vaccines Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Conjugate Vaccines Import & Export
- 6.5 China
- 6.5.1 China Conjugate Vaccines Production Growth Rate 2014-2019
- 6.5.2 China Conjugate Vaccines Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Conjugate Vaccines Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Conjugate Vaccines Consumption by Regions
- 7.1 Global Conjugate Vaccines Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Conjugate Vaccines Consumption by Type
- 7.2.2 United States Conjugate Vaccines Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Conjugate Vaccines Consumption by Type
- 7.3.2 European Union Conjugate Vaccines Consumption by Application
- 7.4 China
- 7.4.1 China Conjugate Vaccines Consumption by Type
- 7.4.2 China Conjugate Vaccines Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Conjugate Vaccines Consumption by Type
- 7.5.2 Rest of World Conjugate Vaccines Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Novartis
- 8.1.1 Novartis Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Conjugate Vaccines
- 8.1.4 Conjugate Vaccines Product Introduction
- 8.1.5 Novartis Recent Development
- 8.2 Neuron Biotech
- 8.2.1 Neuron Biotech Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Conjugate Vaccines
- 8.2.4 Conjugate Vaccines Product Introduction
- 8.2.5 Neuron Biotech Recent Development
- 8.3 Serum Institute of India
- 8.3.1 Serum Institute of India Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Conjugate Vaccines
- 8.3.4 Conjugate Vaccines Product Introduction
- 8.3.5 Serum Institute of India Recent Development
- 8.4 Pfizer
- 8.4.1 Pfizer Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Conjugate Vaccines
- 8.4.4 Conjugate Vaccines Product Introduction
- 8.4.5 Pfizer Recent Development
- 8.5 Sanofi Pasteur
- 8.5.1 Sanofi Pasteur Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Conjugate Vaccines
- 8.5.4 Conjugate Vaccines Product Introduction
- 8.5.5 Sanofi Pasteur Recent Development
- 8.6 Bharat Biotech
- 8.6.1 Bharat Biotech Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Conjugate Vaccines
- 8.6.4 Conjugate Vaccines Product Introduction
- 8.6.5 Bharat Biotech Recent Development
- 8.7 Biological
- 8.7.1 Biological Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Conjugate Vaccines
- 8.7.4 Conjugate Vaccines Product Introduction
- 8.7.5 Biological Recent Development
- 8.8 GlaxoSmithKline
- 8.8.1 GlaxoSmithKline Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Conjugate Vaccines
- 8.8.4 Conjugate Vaccines Product Introduction
- 8.8.5 GlaxoSmithKline Recent Development
- 8.9 Merck
- 8.9.1 Merck Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Conjugate Vaccines
- 8.9.4 Conjugate Vaccines Product Introduction
- 8.9.5 Merck Recent Development
- 8.10 CSL
- 8.10.1 CSL Company Details
- 8.10.2 Company Description and Business Overview
- 8.10.3 Production and Revenue of Conjugate Vaccines
- 8.10.4 Conjugate Vaccines Product Introduction
- 8.10.5 CSL Recent Development
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Conjugate Vaccines Capacity, Production Forecast 2019-2025
- 9.1.2 Global Conjugate Vaccines Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Conjugate Vaccines Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Conjugate Vaccines Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Conjugate Vaccines Production Forecast by Type
- 9.7.2 Global Conjugate Vaccines Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Conjugate Vaccines Sales Channels
- 10.2.2 Conjugate Vaccines Distributors
- 10.3 Conjugate Vaccines Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Conjugate Vaccines. Industry analysis & Market Report on Conjugate Vaccines is a syndicated market report, published as Global (United States, European Union and China) Conjugate Vaccines Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Conjugate Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
